Hypertension 2025 Scientific Sessions  /  Rethinking the Box: When Using Less Traditional Blood Pressure Reduction Strategies Delivers More  /  Emerging Therapeutics for Treatment of Hypertension: New Oral and Parenteral Options
Logo

American Heart Association

  61
  0

Final ID:

Emerging Therapeutics for Treatment of Hypertension: New Oral and Parenteral Options

  • Schlaich, Markus  ( UNIVERSITY OF WESTERN AUSTRALIA , Perth , Western Australia , Australia )
    • Author Disclosures:
    Markus Schlaich: DO have relevant financial relationships ; Researcher:Medtronic:Active (exists now) ; Researcher:ReCor:Active (exists now) ; Researcher:Abbott:Active (exists now)
Meeting Info:

Hypertension 2025 Scientific Sessions

2025

Baltimore, Maryland

Session Info:

Rethinking the Box: When Using Less Traditional Blood Pressure Reduction Strategies Delivers More

Saturday, 09/06/2025 , 04:30PM - 05:30PM

Primary Care

More abstracts on this topic:
Identity Re-Boot: SGLT2/GLP1RAs as Blood Pressure Drugs

Derington Catherine

How to implement stress reduction in BP management: Pharmacological and non-phamacological intervention

Hines Anika

More abstracts from these authors:
Assessing the Impact of Aprocitentan on Systolic and Diastolic BP in Patients with Isolated Systolic Hypertension (ISH)-like Characteristics

Flack John, Narkiewicz Krzysztof, Schlaich Markus, Wang Jiguang, Weber Michael

The effect of aprocitentan in patients with very high blood pressure at baseline

Weber Michael, Narkiewicz Krzysztof, Schlaich Markus, Wang Jiguang, Flack John

You have to be authorized to contact abstract author. Please, Login
Not Available